Search

Your search keyword '"Eicher J"' showing total 288 results

Search Constraints

Start Over You searched for: Author "Eicher J" Remove constraint Author: "Eicher J"
288 results on '"Eicher J"'

Search Results

1. Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler

2. Reducing Selection Bias in Large Language Models

3. Development of Respimat® Soft Mist™ Inhaler and its clinical utility in respiratory disorders

4. Compensatory Biases Under Cognitive Load: Reducing Selection Bias in Large Language Models

5. Are the PAH risk stratification tools useful in post-capillary pulmonary hypertension? Insights from the PH-HF study

6. Phenotype, genotype and prognosis of apical hypertrophic cardiomyopathies: A French multicentric cohort

7. Pulmonary hypertension due to left heart disease: First validation of the 2022 definitions in a prospective study, the PH-HF multicenter study

9. Genome-wide association study of shared components of reading disability and language impairment.

10. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

11. Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group

12. New insights into the genetic etiology of Alzheimer's disease and related dementias

14. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

16. List of Contributors

17. Clinical characteristics and outcomes of worsening heart failure patients with reduced ejection fraction: a French national healthcare database analysis

20. Costs of the New Information Technologies in Education: Characteristics and Problems of Measurement.

21. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

22. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

23. Demographic characteristics of the 1902 transthyretin amyloid cardiomyopathy patients treated by tafamidis through the French early access program

26. Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices

27. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

28. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

31. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

32. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

33. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

34. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

36. Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

37. Genetic architecture of subcortical brain structures in 38,854 individuals worldwide

38. Prognosis of adults with left ventricular non compaction: Results from a prospective multricentric french study

47. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

48. Pharmacological treatment of patients with HFrEF: is it really optimized in case of CRT and/or ICD implantation?

49. Genetic architecture of subcortical brain structures in 38,851 individuals

50. Genetic architecture of human plasma lipidome and its link to cardiovascular disease

Catalog

Books, media, physical & digital resources